Flavonoid Ve Çay Tüketimi İle Kardiyovasküler Hastalıklar Arasındaki İlişkiler

Öz

diyovasküler hastalıklar, mide hastalıkları ve çeşitli sağlık sorunları olan kişilere ve özellikle yaşlılara genellikle çayı azaltmaları ya da içmemeleri önerilmektedir. Böyle bir öneri olmasa bile rahatsızlıkları olanların, yaşlıların ya da sağlık konusunda titiz kişilerin sağlık kaygıları nedeniyle çaydan uzak durmaya çalıştıkları gözlenmektedir.

Association Of Flavonoids And Tea Intake Between Cardiovascular Disease

Abstract

References

1. Weisburger JH. Tea and health: the underlying mechanisms. Proc Soc Exp Biol Med 1999; 220 (4): 271-75.
2. Rimm EB, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. [Abstract]. Ann Intern Med 1996; 125 (5): 384-89.
3. Kritz H, Sinzinger H. Tea consumption, lipid metabolism, and atherosclerosis. [Abstract]. Wien Klin Wochenschr 1997; 109 (24): 944-48.
4. Hollman PC, Feskens EJ, Katan MB. Tea flavonols in cardiovascular disease and cancer epidemiology. [Abstract]. Proc Soc Exp Biol Med. 1999; 220 (4): 198-202.
5. Hollman PC, Katan MB. Bioavailability and health effects of dietary flavonols in man. Arch Toxicol Suppl 1998; 20: 237-48.
6. Middleton ER. Effect of plant flavonoids on immune and inflammatory cell function. Adv Exp Med Biol 1998; 439: 175-82.
7. Bohm H, Boeing H, Hempel J, Raab B, Krodke A. Flavonols, flavone and anthocyanins as natural antioxidants of food and their possible role in the prevention of chronic diseases. [Abstract]. Z Ernahrungswiss 1998; 37 (2): 147-63.
8. Constant J. Alcohol, ischemic heart disease, and the French paradox. Coron Artery Dis 1997; 8 (10): 645-49.

9. da Luz PL, Serrano Junior CV, Chacra AP, Monteiro HP, Yoshida VM, Furtado M, Ferreira S, Gutierrez P, Pileggi F. The effect of red wine on experimental atherosclerosis: lipid-independent protection. Exp Mol Pathol 1999; 65 (3): 150-59.
10. Prior RL, Cao G. Antioxidan capacity and polyphenolic components of teas. Proc Soc Exp Biol Med 1999; 220 (4): 255-61.
11. Beecher GR, Warden BA, Merken H. Analysis of tea polyphenols. Proc Soc Exp Biol Med 1999; 220 (4): 267-70.
12. Bravo L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 1998; 56 (11): 317-33.
13. Carcia-Closas R, Agudo A, Gonzalez CA, Riboli E. Intake of specific carotenoids and flavonoids and the risk of lung cancer in women in Barcelona, Spain. Nutr Cancer 1998; 32 (3): 154-58.
14. Işıksoluğu MK. Kahve ile serum lipitleri ve koroner kalp hastalığı arasındaki ilişkiler. Gıda Dergisi 1994; 19 (5) : 323-28.
15. Işıksoluğu MK. Kafein ve kan basıncı. F.Ü. Sağlık Bil Dergisi 1994; 8 (1): 118-124.
16. Hara Y. The effects of tea polyphenols on cardiovascular diseases. Prevent Med 1992; 21: 333 A.
17. Bingham SA, Vorster H, Jerling JC, Magee E, Mulligan A et al. Effect of black tea drinking on blood lipids, blood pressure and aspects of bowel habit. Brit J Nutr 1997; 78: 41-48
18. Imai K, Nakachi K. Cross sectional study of effects on drinking green tea on cardiovascular and liver diseases. Brit Med J 1995; 310: 693-97.
19. Işıksoluğu MK. Kan basıncı ile vücut ağırlığı ve beslenme alışkanlığı arasındaki ilişkiler. Türk Hij Den Biyol Dergisi 1996; 53: 25-29.
20. Rakic V, Beilin LJ, Burke V. Effect of coffee and tea drinking on postprandial hypotension in older men and women. Clin Exp Pharmacol Physiol 1996; 23 (6-7): 559-63.
21. Kark CD, Friedlander Y, Kaufman NA, Stein Y. Coffee, tea and plasma cholesterol. The Jerusalem Lipid Research Clinic Prevalense Study. Br Med J 1985; 291: 699.
22. İlhan N, Sondaç Ü, Özdemir Y, Işıksoluğu M. (1992). Kan lipitleri ile vücut ağırlığı, yaş, cinsiyet, çay ve sigara arasındaki ilişkiler. Doğa, Tr. J. of Medical Sciences. 1992; 16: 468-74.
23. Katiyar SK, Matsui MS, Elmets CA, Mukhtar H. Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin.[Astract]. Photochem Photobiol 1999; 69 (2): 148-53.
24. Yochum L, Kushi LH, Meyer K, Folsom AR. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women Am J Epidemiol 1999; 15; 149 (10): 943-49.
25. Aucamp J, Gazpar A, Hara Y, Apostolides Z. Inhibition of xanthine oxidase by catechins from tea (Camellia sinensis). Anticancer Res 1997; 17(6D): 4381-5.
26. Vinson JA. Flavonoids in foods as in vitro and in vivo autioxidants. Adv Exp Med Biol 1998; 439: 151-64.
27. van het Hof KH, de Boer HS, Wiseman SA, Lien N, Westrate JA, Tijburg LB. Consumption of green or black tea does not increase resistance of low-density lipopratein to oxidation in humans. Am J Clin Nutr 1997; 66 (59): 1125-32.
28. Ishikawa T, Suzukawa M, Ito T, Yoshida H, Ayari M, Nishiwaki M, Yonemura A, Hara Y, Nakamura H. Effect of tea flavonid supplementation on suspectibilty of low-density lipoprotein to oxidative modification. Am J Clin Nutr 1997; 66 (2): 261-66.
29. van het Hof KH, Wiseman SA, Tijburg LB. Plasma and lipoprotein levels of tea catechins following repeated tea consumption of green or black tea does not increase resistance of low-density lipopratein to oxidation in humans. Am J Clin Nutr 1997; 66 (59): 1125-32.
30. Klatsky AL, Petitti DB, Armstrong MA, Friedman GD. Coffee, tea and cholesterol. Am J Cardiol 1985; 55: 577-82.
31. Klatsky AL, Armstrong MA, Friedman GD. Coffee use prior to myocardial infarction restudied: Heavier intake may increase the risk. Am J Epidemiol 1990; 132 (3): 479.
32. Brown CA, Bolton-Smith C, Woodward M, Tunstall-Pedoe H. Coffee and tea consumption and the prevalence of coronary heart disease in men and women: results from the Scottish Heart Health Study. [Abstract]. J Epidemiol Community Health 1993; 47 (3): 171-5
33. Hertog MG, Sweetnam PM, Fehily AM, Elwood PC, Kromhout D. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: [Abstract]. the Caerphilly Study. Abst. Am J Clin Nutr 1997; 65 (5): 1489-94. 34.
34. Sesso H, Gaziano M, Burung JE and Hennekens CH. Coffee and tea intake and the risk of myocardial infarction. Am J of Epidemiol 1999; 149: 162-67.
35. Soleas GJ, Diamandis EP, Goldberg DM. Wine as a biological fluid: history, production, and role in disease prevention. [Abstract]. J Clin Lab Anal 1997; 11 (5) : 287-313.